Full Year 2023 Investor Presentation

124 Investor presentation Full year 2023 Diabetes market share and market growth in Region China Diabetes market growth and Novo Nordisk market share 40% 30% 20% DKK billion 40% 32% 20% Diabetes market size and growth 28 --10% 0 -1 Region China 25 -2 0% ~-11% 10% -10% 32% 32% -11% 0% -20% Nov 2020 -NN market share Nov Market growth (right axis) 2023 Nov 2022 NN Company A Others Nov 2023 Novo Nordisk Competitors NN growth (right axis) NN: Novo Nordisk Note: Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. Region China covers Mainland China, Taiwan, and Hong Kong; Market values are based on the list prices Source: IQVIA, Nov 2023, Value, MAT

View entire presentation